about
The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteinsHsp90 inhibitor 17-DMAG decreases expression of conserved herpesvirus protein kinases and reduces virus production in Epstein-Barr virus-infected cellsCCAAT/enhancer binding proteins alpha and beta regulate the tumor necrosis factor receptor 1 gene promoter.Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infectionAn EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse modelB cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection
P50
Q34291099-5296FB73-644B-41FB-8D09-92858C433E08Q37123188-647E5841-F208-4C77-ADE8-B2717F3AE77BQ37299649-4FCDC372-BF2C-4A22-869E-C2A9EC0A3040Q40375799-849E960D-1C95-4320-9C5F-588525E0F467Q56355742-AB47CF8C-4722-478C-ABDF-63664ABE0DCEQ57025486-25AD9B62-66DE-450B-8AC4-7CCE594473D2Q89717789-86ADB5B6-248F-42D1-B35A-B196EC2BAAE5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jillian A Bristol
@ast
Jillian A Bristol
@en
Jillian A Bristol
@es
Jillian A Bristol
@nl
Jillian A Bristol
@sl
type
label
Jillian A Bristol
@ast
Jillian A Bristol
@en
Jillian A Bristol
@es
Jillian A Bristol
@nl
Jillian A Bristol
@sl
prefLabel
Jillian A Bristol
@ast
Jillian A Bristol
@en
Jillian A Bristol
@es
Jillian A Bristol
@nl
Jillian A Bristol
@sl
P106
P31
P496
0000-0001-6109-8126